The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2014
Filed:
Apr. 16, 2010
Applicants:
Shizuo Kasai, Kanagawa, JP;
Kevin Francis Mcgee, Jr., New York, NY (US);
Inventors:
Shizuo Kasai, Kanagawa, JP;
Kevin Francis McGee, Jr., New York, NY (US);
Assignee:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/495 (2006.01); C07D 295/00 (2006.01); C07D 207/416 (2006.01); C07D 335/02 (2006.01); C07D 231/18 (2006.01); C07D 295/215 (2006.01); C07D 261/18 (2006.01); C07D 209/24 (2006.01); C07D 209/18 (2006.01); C07D 295/185 (2006.01); C07D 213/75 (2006.01); C07D 211/88 (2006.01); C07D 263/34 (2006.01); C07D 513/04 (2006.01); C07D 213/70 (2006.01); C07D 213/65 (2006.01); C07D 235/28 (2006.01); C07D 233/72 (2006.01); C07D 233/64 (2006.01); C07D 307/24 (2006.01); C07D 211/76 (2006.01); C07D 231/14 (2006.01); C07D 211/58 (2006.01); C07D 233/90 (2006.01); C07D 257/04 (2006.01); C07D 211/46 (2006.01); C07D 213/61 (2006.01); C07D 261/12 (2006.01); C07D 209/42 (2006.01); C07D 207/16 (2006.01); C07D 211/22 (2006.01); C07D 307/30 (2006.01); C07D 233/34 (2006.01); C07D 309/38 (2006.01); C07D 249/10 (2006.01); C07D 211/34 (2006.01); C07D 213/81 (2006.01); C07D 207/26 (2006.01);
U.S. Cl.
CPC ...
C07D 295/185 (2013.01); C07D 207/416 (2013.01); C07D 335/02 (2013.01); C07D 231/18 (2013.01); C07D 295/215 (2013.01); C07D 261/18 (2013.01); C07D 209/24 (2013.01); C07D 209/18 (2013.01); C07D 213/75 (2013.01); C07D 211/88 (2013.01); C07D 263/34 (2013.01); C07D 513/04 (2013.01); C07D 213/70 (2013.01); C07D 213/65 (2013.01); C07D 235/28 (2013.01); C07D 233/72 (2013.01); C07D 233/64 (2013.01); C07D 307/24 (2013.01); C07D 211/76 (2013.01); C07D 231/14 (2013.01); C07D 211/58 (2013.01); C07D 233/90 (2013.01); C07D 257/04 (2013.01); C07D 211/46 (2013.01); C07D 213/61 (2013.01); C07D 261/12 (2013.01); C07D 209/42 (2013.01); C07D 207/16 (2013.01); C07D 211/22 (2013.01); C07D 307/30 (2013.01); C07D 233/34 (2013.01); C07D 309/38 (2013.01); C07D 249/10 (2013.01); C07D 211/34 (2013.01); C07D 213/81 (2013.01); C07D 207/26 (2013.01);
Abstract
The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, which has a superior RBP4-lowering action and is useful as a pharmaceutical composition for the prophylaxis or treatment of a disease or condition mediated by an increase in RBP4.